India · Delayed Price · Currency is INR Ajanta Pharma Statistics
Total Valuation
Ajanta Pharma has a market cap or net worth of INR 364.68 billion. The enterprise value is 357.74 billion.
| Market Cap | 364.68B |
| Enterprise Value | 357.74B |
Important Dates
The last earnings date was Friday, January 30, 2026.
| Earnings Date | Jan 30, 2026 |
| Ex-Dividend Date | Nov 10, 2025 |
Share Statistics
| Current Share Class | 124.89M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.41% |
| Shares Change (QoQ) | -0.02% |
| Owned by Insiders (%) | 42.34% |
| Owned by Institutions (%) | 20.81% |
| Float | 41.84M |
Valuation Ratios
The trailing PE ratio is 35.95 and the forward PE ratio is 30.37.
| PE Ratio | 35.95 |
| Forward PE | 30.37 |
| PS Ratio | 7.01 |
| PB Ratio | 8.45 |
| P/TBV Ratio | 8.53 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 35.26 |
| EV / Sales | 6.88 |
| EV / EBITDA | 25.71 |
| EV / EBIT | 28.58 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.06 |
| Debt / EBITDA | 0.18 |
| Debt / FCF | n/a |
| Interest Coverage | 63.15 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 26.98% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 5.40M |
| Profits Per Employee | 1.05M |
| Employee Count | 9,628 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Ajanta Pharma has paid 2.85 billion in taxes.
| Income Tax | 2.85B |
| Effective Tax Rate | 21.95% |
Stock Price Statistics
The stock price has increased by +16.31% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +16.31% |
| 50-Day Moving Average | 2,746.36 |
| 200-Day Moving Average | 2,614.73 |
| Relative Strength Index (RSI) | 65.48 |
| Average Volume (20 Days) | 5,615 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Ajanta Pharma had revenue of INR 52.02 billion and earned 10.15 billion in profits. Earnings per share was 81.21.
| Revenue | 52.02B |
| Gross Profit | 39.67B |
| Operating Income | 12.52B |
| Pretax Income | 13.00B |
| Net Income | 10.15B |
| EBITDA | 13.80B |
| EBIT | 12.52B |
| Earnings Per Share (EPS) | 81.21 |
Balance Sheet
The company has 9.40 billion in cash and 2.46 billion in debt, with a net cash position of 6.94 billion.
| Cash & Cash Equivalents | 9.40B |
| Total Debt | 2.46B |
| Net Cash | 6.94B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 43.15B |
| Book Value Per Share | 345.45 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 76.27%, with operating and profit margins of 24.06% and 19.50%.
| Gross Margin | 76.27% |
| Operating Margin | 24.06% |
| Pretax Margin | 24.99% |
| Profit Margin | 19.50% |
| EBITDA Margin | 26.52% |
| EBIT Margin | 24.06% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 28.00, which amounts to a dividend yield of 0.98%.
| Dividend Per Share | 28.00 |
| Dividend Yield | 0.98% |
| Dividend Growth (YoY) | -48.15% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.41% |
| Shareholder Yield | 1.39% |
| Earnings Yield | 2.78% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 22, 2022. It was a forward split with a ratio of 1.5.
| Last Split Date | Jun 22, 2022 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |